PhibroMonensin 400 Monensin Feed Additive Premix

Country: Australia

Language: English

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Active ingredient:

MONENSIN AS MONENSIN SODIUM

Available from:

PHIBRO ANIMAL HEALTH PTY LIMITED

Pharmaceutical form:

ORAL POWDER, PRE-MIX

Composition:

MONENSIN AS MONENSIN SODIUM ANTIPROTOZOAL Active 400.0 g/kg

Units in package:

25kg

Class:

VM - Veterinary Medicine

Therapeutic area:

NUTRITION & METABOLISM

Product summary:

Poison schedule: 4; Withholding period: WITHHOLDING PERIOD (Cattle): Meat: Nil. Milk: Nil. WITHHOLDING PERIOD (Goats): Meat: Nil. Milk: DO NOT USE PAHMonensin 400 in goats producing milk that may be used or processed for human consumption . WITHHOLDING PERIOD (Poultry): Meat: N il. Eggs: DO NOT USE in birds producing eggs for human consumption. EXPORT SLA UGHTER INTERVAL (ESI): An ESI has not be en established for this product. Note - observing the meat withholding period m ay not be sufficient to mitigate potenti al risks to export trade. Trade advice should be sought from Phibro Animal Heal th Pty Ltd on 02 9616 3750 before using the product.; Host/pest details: CATTLE: [COCCIDIOSIS]; CATTLE - FEEDLOT: [BLOAT, IMPROVE FEED EFFICIENCY]; DAIRY CATTLE: [BLOAT, IMPROVEMENT OF MILK PRODUCTION]; DAIRY CATTLE LACTATING: [KETOSIS]; GOAT: [COCCIDIOSIS]; HEIFER: [IMPROVE FEED EFFICIENCY, IMPROVE REPRODUCTIVE PERFORMANCE]; POULTRY - SEE LABEL: [COCCIDIOSIS]

Authorization status:

Registered

Authorization date:

2023-07-01

Patient Information leaflet

PAHmonensin 400
86885/116897
Product Name:
APVMA Approval No:
Label Name:
PAHmonensin 400
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS BEFORE OPENING OR USING
Constituent
Statements:
400 g/kg Monensin (as monensin sodium)
Claims:
FEEDLOT CATTLE: For improved feed efficiency. As an aid in the control
of bloat.
CATTLE: As an aid in the prevention of coccidiosis caused by Eimeria
zuernii and Eimeria
bovis. For increased rate of weight gain and feed efficiency in
heifers. For improved
reproductive performance in heifers.
DAIRY COWS: For increased milk production under some conditions. As an
aid in reducing
the severity of non-clinical ketosis in lactating dairy cows.
As an aid in the control of bloat.
GOATS: As an aid in the prevention of coccidiosis.
POULTRY (Broilers and Replacement layers): As an aid in the prevention
of coccidiosis
caused by Eimeria acervulina, E. brunetti, E. maxima, E. mivati, E.
necatrix, E. tenella.
Net Contents:
25 kg
Directions for Use:
Restraints:
DO NOT USE PAHMonensin 400 in goats producing milk that may be used or
processed
for human consumption.
DO NOT USE in chickens producing eggs for human consumption.
Contraindications:
Dogs, horses or other equines must not be allowed access to feeds
containing
PAHMonensin. Ingestion by dogs and horses may be fatal.
Precautions:
The recommended level of PAHmonensin 400 must not be exceeded. High
levels
may cause decreased feed intake, poor growth, diarrhoea and death.
Responses RLP APPROVED
to PAHmonensin 400 are unlikely if nutrient intake is severely
restricted. Feeding
PAHmonensin 400 to lactating cows may result in decreased milk fat
percentage but
there is no effect on total fat yield. Tiamulin should not be
administered in poultry when
PAHmonensin 400 is being fed in the ration - severe growth depression
or death may
occur.
Side Effects:
Dosage and
Administration:
This section contains file attachment.
General Directions:
Withholding Periods:
WITHHOLDING PERIOD (Ca